| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0005 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0007 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |